Biography
She strives to work with patients to develop care plans that are comprehensive and personalized achieve the best possible outcomes and quality of life.
Dr. Dolezal also has extensive experience in research and drug development. She previously held positions as a clinical scientist, assistant medical director, and associate medical director in the BioOncology Therapeutics unit of the biotechnology company Genentech.
She has conducted clinical research into fertility preservation in patients with breast cancer, advanced treatments for triple-negative breast cancer, and patients’ adherence to anti-cancer therapy. She has co-authored articles on her research findings that appeared in the Journal of Clinical Oncology, Cancer, and other peer-reviewed publications.
She also co-authored the chapter “Progression from Hormone-Dependent to Hormone-Independent Breast Cancer” in the textbook Hormones, Genes and Cancer published by Oxford University Press.
Dr. Dolezal has made presentations to her peers at meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and European Cancer Organisation.
Professional Summary
Education & Certifications
- Medical Education: Sidney Kimmel Medical College Thomas Jefferson University (1999) PA
- Board Certification: American Board of Internal Medicine, Hematology (2007)
- Board Certification: American Board of Internal Medicine, Medical Oncology (2006)
-
- Fellowship: UCLA Division of Hematology and Oncology (2005) CA
- Residency: USC/LAC Medical Center (2002) CA
Honors & Awards
- Foerderer Scholarship for International Study on HIV Education in Africa, International AIDS Society
- General Honors Program, University of Maryland
- Gibbon Scholar, Thomas Jefferson Medical College and Graduate School
-
- House of Delegates Scholarship, Maryland Higher Education Commission
- Ironman Finisher, Ironman Triathlon
- President, Medical Students for Choice, Jefferson Medical College
- Research Scholarly Committee, University of Southern California Department of Medicine
- Senatorial Scholarship, Maryland
- Speaker at NIH as Tour of Hope Representative and Former NIH Researcher, National Institutes of Health (NIH)
- Sponsored Athlete, Zoom Elite Triathlon Team
- Team USA Triathlon Age-Group Division World Championships, Team USA - USA Triathlon
- Tour of Hope Rider Across the USA, Tour de Hope
- Triathlon and Cycling Coach, Leukemia & Lymphoma Society Team in Training (TNT)
Publications
-
Immunophenotypic and genotypic characterization of progression in follicular lymphomas
Natkunam, Y., Soslow, R., Matolcsy, A. A., Dolezal, M., Bhargava, V., Knowles, D. M., & Warnke, R. (2004). Immunophenotypic and genotypic characterization of progression in follicular lymphomas. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 12(2), 97–104. -
CLONAL VDJ RECOMBINATION OF THE IMMUNOGLOBULIN HEAVY-CHAIN GENE BY PCR IN CLASSICAL HODGKINS-DISEASE
Kamel, O. W., Chang, P. P., Hsu, F. J., DOLEZAL, M. V., Warnke, R. A., & VANDERIJN, M. (1995). CLONAL VDJ RECOMBINATION OF THE IMMUNOGLOBULIN HEAVY-CHAIN GENE BY PCR IN CLASSICAL HODGKINS-DISEASE. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 104(4), 419–23. -
VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME CHARACTERIZED BY CLONAL EPSTEIN-BARR-VIRUS GENOME
DOLEZAL, M. V., Kamel, O. W., VANDERIJN, M., Cleary, M. L., Sibley, R. K., & Warnke, R. A. (1995). VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME CHARACTERIZED BY CLONAL EPSTEIN-BARR-VIRUS GENOME. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 103(2), 189–94. -
-
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Yano, T., Sander, C. A., Clark, H. M., Dolezal, M. V., Jaffe, E. S., & Raffeld, M. (1993). Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene, 8(10), 2741–8. -
Neurocysticercosis and oncogenesis.
Del Brutto, O. H., Dolezal, M., Castillo, P. R., & García, H. H. (2000). Neurocysticercosis and oncogenesis. Archives of Medical Research, 31(2), 151–5. -
Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression.
Ganapati, U., Tan, H. T., Lynch, M., Dolezal, M., de Vos, S., & Gasson, J. C. (2007). Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression. Stem Cells (Dayton, Ohio), 25(8), 1872–80. -
Psychosocial distress screening and the survivorship care plan in the community oncology setting.
Dolezal, M. V., Prishtina, M., Ridgley, L., Hart-Inkster, B., Christensen, K., & Orange, D. (2016). Psychosocial distress screening and the survivorship care plan in the community oncology setting. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau, J. M., Wald, K., Sinha, N., Juarez-Hernandez, F., Harris, E., Cedars, M. I., … Rosen, M. P. (2020). Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer, 126(3), 487–495.
-
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Practice Locations
Cancer Center in Emeryville Emeryville, CA
Emeryville, CACancer Center in Emeryville
5800 Hollis Street
Emeryville , CA 94608
Make An Appointment More Clinic Information Getting HereBreast Cancer Program in Emeryville Emeryville, CA
Emeryville, CABreast Cancer Program in Emeryville
5800 Hollis Street
Emeryville , CA 94608
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Review Summary
Dr. Dolezal is often described as personable, caring, and thorough. She is known for being easy to talk to and taking the time to listen to and address concerns. Patients appreciate her ability to explain complex information clearly, and feel she is knowledgeable about their medical history. Many feel comfortable with her, and value her collaborative approach to care.
The summary was created by AI, based on recent patient reviews. Learn more
Patient Reviews
(141 reviews)
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records